CQM-11222-07555
5 vaccinations
5 coded responses
67 check-ins
5 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 441 / OH
- Registered
- 2021-02-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-11
Registered in v-safe
-
2021-02-11
Dose 1 — Pfizer-BioNTech
- 2021-02-11
- 2021-02-12
- 2021-02-13
- 2021-02-14
- 2021-02-15
- 2021-02-16
- 2021-02-17
- 2021-02-18
- 2021-02-25
- 2021-03-04
-
2021-03-11
Dose 2 — Pfizer-BioNTech
- 2021-03-11
-
2021-03-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Joint pains, Fatigue or tirednessAdult check-in
-
2021-03-13
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling · Joint painsAdult check-in
-
2021-03-14
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Swelling · Joint pains, Fatigue or tirednessAdult check-in
-
2021-03-15
Health check-in — days 1–6 daily, dose 2Feeling: Good · Joint pains, Fatigue or tirednessAdult check-in
- 2021-03-16
-
2021-03-17
Survey response — days 1–6 daily, dose 2MedDRA: Injection site bruising — Feeling: GoodFree text: Colorful bruise 1 inch diameter at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-18
- 2021-03-25
- 2021-04-01
- 2021-04-08
- 2021-04-15
- 2021-04-22
- 2021-06-10
- 2021-09-09
-
2021-11-10
Dose 3 — Pfizer-BioNTech
- 2021-11-11
-
2021-11-12
Survey response — days 1–6 daily, dose 3MedDRA: No adverse event — Feeling: Good · Site: PainFree text: NoMedDRA releases: 2024-11 · check-in free text available
- 2021-11-13
- 2021-11-14
- 2021-11-15
- 2021-11-16
- 2021-11-17
- 2021-11-24
- 2021-12-01
- 2021-12-08
- 2021-12-15
- 2021-12-22
-
2022-02-09
Survey response — 3 months, dose 3MedDRA: Coronary arterial stent insertion, Myocardial infarction — Feeling: Good · Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: Heart attack. Two catheterizations and two stents.MedDRA releases: 2024-11 · check-in free text available
-
2022-02-09
Report sent to call center — 3 months, dose 3Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2022-02-10
-
2022-02-10
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2022-05-10
Dose 4 — Pfizer-BioNTech
- 2022-05-10
- 2022-05-11
- 2022-05-12
- 2022-05-13
- 2022-05-14
- 2022-05-15
- 2022-05-16
- 2022-05-17
- 2022-05-24
- 2022-05-31
- 2022-06-07
- 2022-06-14
- 2022-06-21
- 2022-08-09
-
2022-10-27
Dose 5 — Pfizer-BioNTech
- 2022-10-27
- 2022-10-28
- 2022-10-29
- 2022-10-30
- 2022-10-31
- 2022-11-01
- 2022-11-02
- 2022-11-03
- 2022-11-10
- 2022-11-17
-
2022-11-24
Survey response — day 28, dose 5MedDRA: Body temperature increased, Cough, Rhinorrhoea, Sneezing — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Elevated temperatures (100-102) for four days, runny nose, cough and sneezing. Little chest involvement. With family members one of which got sick followed rapidly by other 3, I being the last. Two took multiple antigen tests all negative.MedDRA releases: 2024-11 · check-in free text available
-
2022-12-01
Survey response — day 35, dose 5MedDRA: Cough, Nasal congestion, Respiratory disorder, Rhinorrhoea — Feeling: FairFree text: Lingering upper respiratory issues. Drainage and nasal congestion with intermittent cough. No fever.MedDRA releases: 2024-11 · check-in free text available
- 2022-12-08
- 2023-01-30
- 2023-04-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-11 | Pfizer-BioNTech | |
| 2 | 2021-03-11 | Pfizer-BioNTech | |
| 3 | 2021-11-10 | Pfizer-BioNTech | No |
| 4 | 2022-05-10 | Pfizer-BioNTech | No |
| 5 | 2022-10-27 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): Colorful bruise 1 inch diameter at injection site
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): No
Release 11 — 3 months, dose 3
Symptoms: Heart attack. Two catheterizations and two stents.
Release 12 — day 28, dose 5
Symptoms: Elevated temperatures (100-102) for four days, runny nose, cough and sneezing. Little chest involvement. With family members one of which got sick followed rapidly by other 3, I being the last. Two took multiple antigen tests all negative.
Release 12 — day 35, dose 5
Symptoms: Lingering upper respiratory issues. Drainage and nasal congestion with intermittent cough. No fever.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Body temperature increased | · | · | ✓ |
| SD | Coronary arterial stent insertion | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Myocardial infarction | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Respiratory disorder | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SRO | Injection site bruising | ✓ | ✓ | ✓ |
| SRO | No adverse event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release